Device Week, 1 October 2020 – MDUFA And MCIT In Spotlight At AdvaMed's MedTech Conference

In this week’s podcast, reporters discuss the high points of the recent AdvaMed MedTech Conference. Ferdous Al-Faruque goes in-depth on FDA comments about user fees, while Brian Bossetta discusses varying points of view on Medicare coverage of breakthrough devices – including the crucial role of real-world evidence.

Listen to the podcast via the player below:

Open Media

Medtech Insight articles addressing topics discussed in this episode:

• Real-World Evidence Deemed Essential For Breakthrough Designations
• US FDA’s Shuren Promises MDUFA Update ‘Relatively Soon’
• AdvaMed’s MedTech ’21: Focus On MCIT, MDUFA At Hybrid Meeting